Miljöpåverkan
Trametinib
Miljörisk:
Användning av trametinib har bedömts medföra försumbar risk för miljöpåverkan.
Nedbrytning:
Det kan inte uteslutas att trametinib är persistent, då data saknas.
Bioackumulering:
Trametinib har hög potential att bioackumuleras.
Läs mer
Detaljerad miljöinformation
Environmental Risk Classification
Predicted Environmental Concentration (PEC)
PEC is calculated according to the following formula:
PEC (μg/L) = (A*109*(100-R))/(365*P*V*D*100) = 1.37*10-6 * A * (100 - R) = 1.37*10-6 * 0.14 * 100 = 0.000019 μg/L = 0.019 ng/L
Where:
A = 0.140572148 kg trametinib (total sold amount API in Sweden year 2021, data from IQVIA).
R = 0 % removal rate (due to loss by adsorption to sludge particles, by volatilization, hydrolysis or biodegradation) = 0, if no data is available.
P = number of inhabitants in Sweden = 10 *106
V (L/day) = volume of wastewater per capita and day = 200 (ECHA default) (ECHA 2008).
D = factor for dilution of waste water by surface water flow = 10 (ECHA default) (ECHA 2008)
Predicted No Effect Concentration (PNEC)
Ecotoxicological studies
Algae (Selenastrum capricornutum) (OECD 201):
NOEC 72 h (growth rate) = 0.04 mg/L (not toxic up to the limit of water solubility) (GlaxoSmithKline Report No 2011N119092_00)
Crustacean (Waterflea, Daphnia magna):
Chronic toxicity
NOEC 21 days = 0.013 mg/L (OECD 211) (not toxic up to the limit of water solubility) (GlaxoSmithKline Report No 2012N139247_00)
Fish (Zebrafish, Danio rerio):
Chronic toxicity
NOEC 28 days (fish body length and dry weight) = 0.004 mg/L (OECD 210) (GlaxoSmithKline Report No 2012N134344_00)
PNEC = 4.0 μg/L / 10 = 0.4 µg/L = 400 ng/L
PNEC (μg/L) = lowest NOEC/10, where 10 is the assessment factor used, if chronic toxicity values for 3 trophic levels are available. NOEC from fish early life-stage toxicity (OECD 210) has been used for this calculation since it is the most sensitive of the three tested species.
Environmental risk classification (PEC/PNEC ratio)
PEC/PNEC = 0.019 ng/L / 400.0 ng/L = 0.0000475 i.e. PEC/PNEC ≤ 0.1 which justifies the phrase "Use of trametinib has been considered to result in insignificant environmental risk."
Degradation
Biotic degradation
Ready degradability:
No data available
Justification of chosen degradation phrase:
As no data on degradation is available for trametinib, the following classification is chosen: The potential for persistence of trametinib cannot be excluded, due to lack of data.
Bioaccumulation
Partitioning coefficient:
Log Kow = 4.04 (OECD 107) (GlaxoSmithKline Report No 2011N117817_00)
Justification of chosen bioaccumulation phrase:
Since log Kow > 4, trametinib has high potential for bioaccumulation.
Excretion (metabolism)
Total dose recovery is low after a 10-day collection period (<50%) following administration of a single oral dose of radiolabeled trametinib as a solution, due to the long half-life. Drug-related material was excreted predominantly in the feces (≥81% of recovered radioactivity) and to a small extent in urine (≤19%). Less than 0.1% of the excreted dose was recovered as parent in urine. (Novartis Core Data Sheet, MEKINIST® (trametinib))
References
-
ECHA 2008, European Chemicals Agency. 2008 Guidance on information requirements and chemical safety assessment. http://guidance.echa.europa.eu/docs/guidance_document/information_requirements_en.htm
-
GlaxoSmithKline Report No 2011N117817_00: GSK1120212B: Determination of partition coefficient (n-octanol:water). Final report: 20 May 2011.
-
GlaxoSmithKline Report No 2011N119092_00: GSK1120212B: Algal growth inhibition test. Final report: 17 June 2011.
-
GlaxoSmithKline Report No 2012N139247_00: GSK1120212B: Daphnia magna reproduction test. Final report: 08 May 2012.
-
GlaxoSmithKline Report No 2012N134344_00: GSK1120212B: Fish early life stage toxicity test. Final report: 06 March 2012.
-
Novartis Core Data Sheet for MEKINIST®(trametinib), Version 2.2, 06 August 2019